Imbruvica
Imbruvica (ibrutinib) is an oral therapy for certain blood cancers, including CLL, MCL, and Waldenström’s macroglobulinemia. It blocks BTK to slow cancer growth. Patients should follow prescribed dosing, monitor for side effects like bleeding or infections, and consult their doctor about safety precautions and potential drug interactions.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Product Informaions:
-
Imbruvica (ibrutinib) is a prescription oral medication used to treat certain blood cancers, including:
-
Chronic lymphocytic leukemia (CLL)
-
Mantle cell lymphoma (MCL)
-
Waldenström’s macroglobulinemia (WM)
-
-
It works by blocking a protein called Bruton’s tyrosine kinase (BTK), which slows the growth of cancer cells.
How to Take Imbruvica
-
Form: Oral capsules
-
Typical dosing: Once daily, as prescribed by your doctor (dose depends on the condition)
-
With or without food: Can be taken with or without a meal
-
Swallowing: Swallow capsules whole; do not crush, chew, or open them
-
Missed dose: If you miss a dose, take it as soon as possible. If it’s almost time for the next dose, skip the missed one—do not double dose.
Imbruvica Side Effects:
-
Diarrhea
-
Fatigue or weakness
-
Muscle or joint pain
-
Nausea and vomiting
-
Bruising or minor bleeding
-
Rash
-
Swelling of hands, feet, or ankles
Warnings
-
-
Bleeding Risk
-
Imbruvica can increase the chance of serious bleeding, including in the brain or stomach.
-
Avoid activities that may cause injury, and report unusual bruising or bleeding immediately.
-
-
Infections
-
Can lower immune defenses, leading to bacterial, viral, or fungal infections.
-
Watch for fever, chills, cough, or other signs of infection.
-
-
Heart Problems
-
Risk of atrial fibrillation (irregular heartbeat) and other heart issues.
-
Seek medical attention for palpitations, shortness of breath, or chest pain.
-
-
High Blood Pressure
-
Blood pressure may rise during treatment; monitoring is important.
-
-
Secondary Cancers
-
Rarely, patients may develop other cancers while on Imbruvica.
-
-
Tumor Lysis Syndrome (TLS)
-
Rapid breakdown of cancer cells can cause serious metabolic problems, especially at the start of treatment.
-
-













Reviews
There are no reviews yet.